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INTRODUCTION 
Some 5,15, 000 women die each year in childbirth, mostly in 
developing countries. Severe bleeding in the postpartum period is 
the single most important cause of maternal deaths worldwide. 
More than half of all maternal deaths occur within 24 hours of 
delivery, most commonly from excessive blood loss. It is estimated 
that some 1,40, 000 women die each year from postpartum 
haemorrhage 
        Third stage of labour is the most important part of labour. This 
is the period from delivery of baby to delivery of placenta. After 
delivery of baby and cessation of umbilical cord pulsation the 
placenta separates from uterine wall through the spongy lining of 
the womb. The placenta separates as a result of capillary 
hemorrhage and the shearing effect of uterine contraction. 
Life threatening complications are common in this stage of 
labour. They are postpartum hemorrhage and retained placenta and 
inversion of uterus. Postpartum hemorrhage is responsible for 25% 
of maternal death. PPH is therefore the most important maternal 
complication in labour and puerperium (AbouZahr2003). It occurs 
in 5% of all deliveries .Retained placenta occurs in 0.1-2%of 
deliveries. A recent study shows statistically significant increase in 
postpartum hemorrhage when the placenta was not delivered within 
18minutes of delivery of baby. (Magnon2005). Primary PPH 
occurs unpredictably in low-risk women.(Prendiville 2000) 
Active management of labour aims at prevention of 
complications of the third stage. This includes prophylactic 
administration of a parenteral oxytocic drug, early clamping of 
umbilical cord and controlled cord traction. 
Recommendations are  
1. AMTSL reduces the risk of PPH and should be offered to all 
women(I-A) 
2. Oxytocin(10units) intramuscularly is the preferred 
medication and route for the prevention of PPH in low risk 
vaginal deliveries. It should be administered after the delivery 
of the anterior shoulder. 
3. Intravenous infusion of oxytocin 20units in1000ml is an 
acceptable alternative for AMTSL 
Expectant management is the “hands off” policy, where 
signs of separation are awaited and the placenta allowed to 
deliver spontaneously or with aid of gravity or nipple 
stimulation 
  Intraumbilical injection of oxytocin for the treatment of 
retained placenta was first described by Mojon and Asdrubali in 
1826(Koerting1926).The length of the third stage of labour, and its 
subsequent complications depends on the length of time  it takes for 
placental separation and the ability of uterine muscle to 
contract.Principal management of third stage of labour aims at 
reducing the time of delivery of placenta so minimising serious 
adverse effects ,such as blood loss and retained placenta. Umbilical 
vein injection  of oxytocin  directs the treatment of the placental 
bed and the uterine wall, resulting in an earlier uterine contraction 
and placental separation. 
The purpose of this study was to find out the effect of  
intraumbilical injection of oxytocin  in comparison with 
intramuscular oxytocin injection  in reducing the blood loss during 
the third and fourth stages of labour, the length of the third stage of 
labour, and the reduction in the incidence of manual removal of 
retained placenta. 
 
 
 
 
 
 
 
 
 
 
 
 
  
AIMS OF THE STUDY 
 
 1. To evaluate the efficacy of intraumbilical injection of 
oxytocin as a prophylactic oxytocic drug in AMSTL 
2. To study the effect of intraumbilical oxytocin in 
 Duration of third stage 
 Blood loss of third stage 
 Complication of third stage 
 Effects on the mother 
     3.  Comparison of 10 units oxtocin Intramuscular injection with 
20 units oxytocin in 20 ml normal saline intraumbilical n 
injection in AMSTL. 
 
 REVIEW OF LITERATURE 
Active management of labour 
  Active management of third stage of labour aims at 
prevention of postpartum hemorrhage. 
(1)  Prendville et al, 2002 
   Routine management was shown to be superior to expectant 
management in that there was a statistically significant reduction in 
the incidence of moderate hemorrhage of 500-1000ml,severe 
hemorrhage over 1000ml,postpartum hemoglobin of less than 
9gms/dl, postnatal blood transfusion the need for therapeutic 
oxytocics and the third stage lasting more than 20minutes.Women 
were more satisfied in the third stage if they had active 
management. These  findings were confirmed in general population 
and also in women considered to be at low risk of third stage 
complication. 
 
 (2) Edgardo abalos and associates, 2006. 
  Compared with expectant management, active management 
of the third stage of labour is associated with a lower incidence of 
postpartum haemorrhage, less blood loss and reduced risk of blood 
transfusion. 
OXYTOCIN AND ITS EFFECTS 
 (3)  Gulmezoglu et al (2002) 
  Oxytocin is closely related to antidiuretic hormone and may 
lead to fluid retention and water intoxication. These are unusual 
side effects and would not be expected in prophylactic low doses. 
However caution is required in women who have received large 
doses of oxytocin for labour augmentation, especially when given 
with large volume electrolyte free intravenous fluids or where there 
is another riskfactor for fluid retention such as pre-eclampsia 
exists(Brucker2001). 
(4)  Secher 1998:    
 Intravenous bolus injections of 10units oxytocin injection causes 
transient but profound hypotension due to peripheral vasodilatation 
in some women. 
(5) NICE 2001 
  In normotensive women this is followed by an increase in 
cardiac output but in women with preexisting hypotension (such as 
in cases of postpartum hemorrhage ) or with a known cardiac 
abnormality cardiac arrest and  maternal death has been reported. 
INTRAUMBILICAL INJECTION OF OXYTOCIN: 
(6) Sataq Rafique et al 2009   
 Active management of third stage gave very good results in this 
study. Use of an injection of saline 100ml and oxytocin5u in 
umbilical vein to prevent the retention of placenta by facilitating 
the placental separation. The incidence of PPH in this study  was 
3.9%. 
TIMING OF CORD CLAMPING: 
(7)  McDonald&Middleton 2008 
 This is the study of active management of the third stage of 
labour :  difference between delayed and early cord clamping.  
 A 2008 Cochrane review compared the effect of maternal 
neonatal outcome on early cord clamping. The results showed no 
difference in the incidence of PPH but an increased of neonatal 
jaundice  requiring phototherapy, higher newborn haemoglobin 
levels upto 6 months of age, and higher ferritin levels at 6months of 
age after late clamping. 
CONTROLLED CORD TRACTION: 
(8)M.L.McCornick-et-al 2002 
  Although there are theoretical complications of active 
management of labour (retained placenta, inversion of uterus, 
avulsion of the cord), the use of active management of labour did 
not increase the incidence of retained placenta and there were no 
reported cases of uterine inversion or cord avulsion in the study 
reviewed  here. To avoid  these complications, however tension 
should not be maintained on the cord if the placenta does not 
descend during the 30-40second of controlled tension during a 
contraction ; the procedure should be repeated with the onset of 
uterine contraction. In addition counter pressure on the lower 
segment of the uterus(towards woman’s head) should always be 
applied to the uterus when tension is placed  on the cord. 
INTRAUMBLICAL INJECTION OF OXYTOCIN IN 
RETAINED PLACENTA: 
(9)Neebha Ojha and associates(2007) 
Active management of third stage by oxytocin – Umblical vein Vs 
Intramuscular use: There was significant blood loss in the 
intraumblical group as compared to intramuscular group. There was 
no difference in the duration of third stage of labour between the 
two groups. Intraumblical oxytocin is technically more difficult to 
administer.   
10)  Tammy SGerstenfeld and associates (2001) 
 Rectal Misoprostol Vs Intravenous oxytocin for the prevention 
of postpartum haemorrhage after vaginal delivery: Rectal 
misoprostal was no more effective than intravenous oxytocin in 
preventing postpartum haemorrhage. 
11) Athavale RD, et al 1991 
 The blood loss within the first hour of delivery (4th stage) is an 
important precipitating factor for puerperal anaemia. Third stage of 
labour is generally managed by observation until separation and 
expulsion of the placenta, which is followed by administration of 
methylergometrine. Delayed separation eventually leads to more 
bleeding. However, if methylergometrine is injected at the time of 
the delivery of anterior shoulder, then the expulsion time decreases 
without the theoretical risk of retained placenta.  
12) Golan et al 1983, proposed that the injection of intra- 
umbilical oxytocin leads to a high concentration of oxytocin at the 
uterine wall and may be the cause of the rapid placental expulsion. 
Intra-umbilical oxytocin is therefore, a useful alternative in patients 
where methylergometrine is contraindicated or in cases where 
intravenous fluids need to be restricted. 
13)  Gungorduuk K,et al 2010. 
  In this prospective, randomized, double-blind trial, 412 
women undergoing vaginal delivery who did not have risk factors 
for postpartum hemorrhage were randomly allocated to receive 
either 20 international units oxytocin diluted with 26 ml saline 
(n=207) or 30 ml saline (n=205) by intraumbilical vein injection. 
Active management of the third stage of labor (prophylactic 
injection of 10 international units oxytocin within 2 minutes of 
birth, early clamping of the umbilical cord, and controlled cord 
traction) was used in both groups. The primary outcome was mean 
blood loss during the third and fourth stages of labor. The mean 
estimated blood loss was significantly lower in women treated with 
oxytocin compared with women in the placebo group (195.3+/-81.0 
mL compared with 288.3+/-134.1 mL, respectively; P<.001). The 
third stage of labor was significantly shorter in the oxytocin group 
than in the placebo group (4.5+/-1.6 minutes compared with 7.9+/-
3.4 minutes, respectively; P<.001). The percentages of placentas 
remaining undelivered beyond 15 minutes were 0% in the oxytocin 
group and 4.4% in the placebo group (P=.002).  
 They concluded as use of intraumbilical injection of oxytocin 
with the active management of the third stage of labor significantly 
reduced postpartum blood loss and the duration of the third stage. 
(14)Nada abud-alhur Al-Ebrahimi, 2006 
  All solutions were given by needle injection method. The use 
of intraumblical injection is a simple method in reducing the need 
for manual removal of placenta and blood loss and all their morbid 
complications. So it is highly  recommended in carefully selected 
cases. The addition of intraumbilical vein syntocinon 10 units 
resulted in marked reduction in amount of blood loss, duration of 
third stage and incidence of retained placenta in comparison to 
intravenous 5 IU oxytocin+0.5 mg ergometrine alone.  
(15)Dahia et al1995 
   In this study the effect of intraumbilical oxytocin on duration and 
amount of blood loss in third stage of labour was studied. Pregnant 
women were randomized into 2 groups of 50 each. Group I was 
managed actively with 10 units of oxytocin diluted in 20 ml saline 
given through umbilical vein immediately after cord claming and 
Group II managed traditionally with oxytocin infusion 10 units in 
250 ml of dextrose saline at rate of 125 ml/hr given after delivery 
of baby. In the study group there was a statistically significant 
decrease in duration of third stage of labour <1.48 min Vs 3.27 
min>, fall in haemoglobin <1.2 g/dl vs 1.96 g/dl> and fall in 
haematocrit <3.88% Vs 7.20%<. It was concluded that 
intraumbilical oxytocin appears to be a useful, safe and practical 
method for active management of third stage However, the amount 
of blood loss during third stage and postpartum decrease in 
haemoglobin and haematocrit values were statistically significantly 
less in study group as compared to control group  
 Five hundred parturient women with low risk singleton term 
pregnancy were enrolled in the study. Two hundred and fifty 
women each were included in the study and control group after 
randomization.  
(16)   Guillermo Carroli et al, 1998 
 In their study, they compared the out come of the intraumbilical 
saline solution + oxytocin and saline solution alone and expectant 
management.  The mean blood loss was 527 ml, 394 ml and 438 ml 
respectively.  Fall in haemoglobin was 1.2, 1.1 and 1.1 respectively.  
The intraumbilical oxytocin injection is effective for retained 
placenta but not for active management.  
 BLOOD COLLECTION BRASSS  V  DRAPE 
17.  B.S. Kodkany et al 2009.   
 Results of the three studies conducted at JNMC, Belgaum, 
Karnataka, India, strongly suggest that the BRASS V drape is a 
accurate and practical tool to measure blood loss occurring in the 
third stage of labour.  The critical component of their trial was the 
development of the specially designed low cost “calibrated” plastic 
collection drape” that would objectively measure the amount of 
blood collected in the immediate post partum period .  While 
among women with little blood loss, the ranges of blood  loss were 
similar in both visual and drape assessment group. 
 
 
 
 
 
 
ACTIVE MANAGEMENT OF THIRD STAGE OF LABOUR 
Active management of third stage include 
 Prophylactic oxytocics 
 Early cord clamping 
 Controlled cord traction for delivery of placenta  
 Uterine massage 
PROPHYLACTIC OXYTOCICS 
 The following agents are used for active management of third 
stage of labour 
 Oxytocin 
 Methergin  
 Syntometrine 
 Misoprostol 
OXYTOCIN: 
 Oxytocin is a naturally occurring uterotonic first reported in 
1953 by Du Vigneaud. The effect of oxytocin is to increase the 
frequency and amplitude of contractions. It has a half life of 3-
5minutes. 
PHARMACOLOGY: 
  Oxytocin is a cyclic nanopeptide. It is secreted by the 
posterior pituitary. It causes contraction of uterus, the effect 
increasing as pregnancy advances due to increase of oxytocin 
receptors near term. 
 It is chemically designated as Cys-Tyr-Ile-Gln-Asn-Cys-Asn-
Cys-Pro-Leu-Gly-NH2 cyclic disulphide and a molecular weight of 
1007.2. 
 ACTIONS: 
 Uterus-oxytocin increases force and frequency of 
uterine contractions.Increased contractility is restricted 
to the fundus and body. 
 Breast –oxytocin contracts myoepithelium of mammary 
alveoli and forces milk into the milk sinusoids.-milk 
ejection reflex. 
 CVS-higher doses causes fall in BP ,reflex tachycardia 
and flushing. The umbilical vessel are markedly 
constricted and may help in their closure. 
 Kidney-high doses exerts an antidiuretic 
action.Pulmonary oedema can occur if large amounts of 
IVfluids and oxytocin are infused together. 
PHARMACOKINETICS: 
  Oxytocin being a peptide,  undergoes enzymatic destruction 
in the gastrointestinal tract but rapidly absorbed from the mucous 
membranes when administered buccally or intranasally. It is 
metabolized in the liver and kidneys. Only small amounts are 
excreted unchanged in the urine. Plasma t1/2 averages 10minutes. 
ROUTE OF ADMINISTRATION: 
  Oxytocin can be administered intravenously or 
intramuscularly, but not orally. 
  Oxytocin causes fluid retention and water intoxication. 
Intravenous bolus dose causes profound hypotension and cardiac 
arrest in women with hypotension. Intraumbilical injection has 
fewer side effects. 
  Oxytocin has fewer side effects compared to ergometrine. 
  Refrigeration is recommended for its storage. 
INDICATIONS: 
 Active management  of third stage of labour. 
 Prevention and treatment of postpartum hemorrhage. 
 Induction of labour  
 Uterine inertia 
 Augmentation ol labour 
 Midtrimester abortion 
   ADVERSE EFFECTS: 
1. Injudicious use causes strong uterine contractions forcing 
fetus through an incompletely dilated birth canal causing 
maternal and fetal soft tissue injury, rupture of uterus, foetal 
asphyxia and death. 
2. Water intoxication especially in toxemia and renal 
insufficiency. 
 
 
TIMING OF PROPHYLACTIC OXYTOCICS: 
  The oxytocics are given at the time of delivery of anterior 
shoulder. However twin delivery has to be excluded as it may prove 
dangerous to the second of the twin. 
SIGNS OF PLACENTAL SEPARATION: 
 Uterus should be globular and firmer. 
 Sudden gush of fresh blood from vagina  
 Uterus rises in the abdomen because the placenta having 
separated, passes down into the lower uterine segment 
where its bulk pushes the uterus upwards. 
 Extravulval lengthening of cord. 
EARLY CORD CLAMPING: 
  The umbilical cord is clamped close to the maternal side of 
the cord. The baby is resuscitated, oropharyngeal clearing of the 
baby done this may take 30 seconds for clamping the cord after 
delivery of the baby .The duration third stage is reduced by early 
cord clamping. A delay of cord clamping of as little as 30seconds 
while holding the baby below the level of placenta may therefore 
be an advantage. 
CONTROLLED CORD TRACTION:  
1. Clamp the cord close to the perineum (once pulsation stops in 
a healthy newborn) and hold in one hand.  
2.  Place the other hand just above the woman’s pubic bone and 
stabilize the uterus by applying counter-pressure during 
controlled cord traction.  
3. Keep slight tension on the cord and await a strong uterine 
contraction (2–3 minutes).  
4. With the strong uterine contraction,   encourage the mother to 
push and very gently pull downward on the cord to deliver the 
placenta. Continue to apply counter-pressure to the uterus.  
5. If the placenta does not descend during 30–40 seconds of 
controlled cord traction, do not continue to pull on the cord: 
Gently hold the cord and wait until the uterus is well contracted 
again. With the next contraction, repeat controlled cord traction 
with counter-pressure.  
6. As the placenta delivers, hold the placenta in two hands and 
gently turn it until the membranes are twisted. Slowly pull to 
complete the delivery.  
7. If the membranes tear, gently examine the upper vagina and 
cervix wearing sterile/disinfected gloves and use a sponge 
forceps to remove any pieces of membrane that are present.  
8. Look carefully at the placenta to be sure none of it is missing. 
If a portion of the maternal surface is missing or there are torn 
membranes with vessels, suspect   retained placental fragments 
and take  appropriate action 
 After placental delivery uterine massage can be given to prevent 
PPH. Studies show that controlled cord traction was associated 
with a lower mean blood loss and a shorter third stage. However 
one study showed 3%incidence of umbilical cord rupture. 
COMPLICATIONS OF THIRD STAGE: 
 Postpartum hemorrhage 
 Retained placenta 
 Inversion uterus 
POSTPARTUM HEMORRHAGE: 
  The diagnosis of PPH is a subjective clinical assessment that 
includes any blood loss that threatens the woman’s hemodynamic 
stability. 
  Primary PPH is defined as blood loss of more than 500ml 
from the genital tract at vaginal delivery, 1000mlat caesarean 
delivery or 1500ml at caesarean hysterectomy. 
 Alternative definitions include a 10% drop in haematocrit, or the 
need for blood transfusion in the first 24 hours of delivery. 
  PPH can be subdivided into third stage hemorrhage when 
bleeding occurs before the expulsion of the placenta, and true PPH 
which occurs after the expulsion of the placenta. 
  Secondary PPH is the excessive blood loss after 24 hours but 
within 6 weeks of delivery. 
  A lower value of 300ml as cutoff has been suggested for 
Asian women because of their lower body mass index. 
 
CAUSES OF POSTPARTUM HEMORRHAGE: 
 Uterine atony is the commonest, complicating 1in20 pregnancies 
and accounting for 80-90% of cases. 
Aetiological factors can be divided into 
 Tone-uterine atony 
 Tissue-retained placenta, blood clots 
 Trauma-genital tract injury 
 Thrombin-disseminated intravascular coagulation 
Risk factors: 
 Multiparity 
 H/o PPH 
 Multiple pregnancy 
 Placenta praevia 
 Abruption placenta 
 Prolonged labour 
 Precipitate labour 
 Chorioamnionitis 
 General anaesthesia 
 Polyhydramnios 
 Intrauterine death 
 Uterine fibroids 
    Signs and symptoms of PPH: 
Blood loss% of 
blood volume 
Systolic blood 
pressure mm of Hg 
Signs and symptoms 
10-15 Normal Postural hypotension and 
mild tachycardia 
15-30 Slight fall Tachycardia, thirst, 
weakness 
30-40 60-80 Pallor, oliguria, 
confusion, Tachypnea 
restlessness 
40+ 40-60 Anuria,air hunger , 
coma, death 
 
 
PREVENTION OF PPH: 
 Proper antenatal care 
 antepartum correction of anemia 
 active management of third stage of labour which aims at 
prevention and decrease of blood loss. The primary goal was 
to assist placental delivery, thereby allowing uterus to 
contract and reduce blood flow across the 
myometrium.(Prendiville  and colleagues) 
 skilled attendants should offer uterotonics to prevent PPH. 
 careful postpartum observation of the patient  
 management of patients at risk for PPH in an institution 
where all facilities for management of PPH are available 
RETAINED PLACENTA 
  Retained placenta is defined in various ways. The most 
common definition is retention of the placenta in utero for more 
than 30 minutes. This is an arbitrary definition, and management is 
greatly influenced by the clinical assessment of whether significant 
bleeding is occurring. This bleeding may be visible or may 
manifest only by the increasing size of the uterus. In the absence of 
any evidence of placental detachment, consider the diagnosis of 
complete placenta accreta or a variant. This condition may be 
present with bleeding if only a portion of the placenta is abnormally 
implanted 
 The definitions of retained placenta range from 15-60 minutes 
without placental delivery but are most commonly 20-30 
minutes. Injections into the cord vein have used isotonic sodium 
chloride solution (normal saline), oxytocin and saline, 
prostaglandin and saline, misoprostol and saline, and dextran 70. 
Uterine inversion 
  This condition is very rare. The risk of uterine inversion is 
increased in abnormalities of placentation, such as accreta, and is 
more likely with fundal cord insertions and any condition that 
predisposes patients to uterine atony and prolapse. Cord traction 
should never occur without countertraction or in the absence of 
uterine contraction. Leave the placenta attached, and focus 
management on maternal resuscitation and rapid return of the 
uterus to the abdominal cavity. 
  The fingers are formed into a single cone-shaped unit and 
placed at the most dependent portion of the protruding mass, which 
represents the inverted uterine fundus. Gentle upward pressure is 
exerted in the axis of the birth canal with the fingers and thumb 
together to minimize the risk of uterine perforation. The action has 
been likened to that of placing the fingers at the toe of an inside-out 
sock and pushing to make the sock right-side out. Following uterine 
replacement vigorous massage and uterotonic administration should 
undertaken. 
  Manual removal of the placenta may be performed when the 
mother's vital signs are stable unless concern exists regarding 
abnormal placentation. Uterine relaxants, such as nitroglycerin, 
may be helpful. 
 
 
 
MATERIALS AND METHODS 
  In this randomized comparative study 200 patients attending 
Government Rajaji Hospital Madurai for confinement during the 
period from November 2009 to October 2010 were recruited. They 
were divided into 2 groups. 
GROUP-A - 100 patients received prophylactic 10 units IM 
Oxytocin inj. at the time of delivery of anterior shoulder.   
GROUP-B - 100 patients received Prophylactic 20units 
Oxytocin   in 20ml   Normal saline  intraumbilically after early 
cord clamping. 
INCLUSION CRITERIA: 
 Gestational age between 37-42weeks 
 Singleton pregnancy 
 Live fetus 
 Cephalic presentation 
 Parity between 1 and 5 
 Maternal age less than 35 years 
 Vaginal birth 
 
EXCLUSION CRITERIA: 
 placental abruption 
 placenta praevia 
 history of any bleeding during pregnancy 
 history of curette 
 previous caesarean section or any uterine scar 
 history of postpartum hemorrhage 
 polyhydramnios 
 signs and symptoms of maternal infections 
 coagulation defects 
 known uterine anomalies 
 hemoglobin concentration less than 8 gms 
 history of any medication during pregnancy 
 prolongation of first stage of labour >15 hours 
 
 
METHODS 
GROUP-A 
1OO patients were managed with 10 units oxytocin injection 
intramuscularly at the time of delivery of anterior shoulder. 
GROUP-B 
100 patients were given 20units oxytocin diluted in 20 ml 
normal saline intraumbilical  after early cord clamping 
Blood loss was measured by a Blood collection Drape which 
was placed under the buttocks of the patient after the delivery 
of the baby so that the amniotic fluid is not included.This drape 
is left in place for one hour after delivery.  
Blood soaked swabs were weighed and the known weight 
subtracted. 
Other uterotonics were used if the blood loss was more or when 
the uterus was flabby. 
  Depending on the hemodynamic status of the patient and 
haemoglobin status in postnatal period blood transfusion or iron 
sucrose injection  were given. 
 Side effects were asked for 24hours after delivery. 
In each case following parameters were monitored 
1. Hemoglobin before &after delivery 
2. Vitals before and after delivery 
3. Duration of active stage+second stage 
4. Labour-spontaneous or induced 
5. Labour accelerated or not 
6. Mode of delivery whether  
labour natural or labour natural with lacerated perineum 
or labour natural with episiotomy or outlet forceps with 
episiotomy 
7. Birth weight 
8. Amount of blood loss 
9.     Duration of third stage 
10. Need for blood transfusion 
11. Need for iron sucrose 
12. Need for other oxytocics 
13. Presence of PPH or retained placenta requiring manual 
removal 
14. Side effects of drugs 
MEASUREMENT OF BLOOD LOSS 
 The amount of blood loss is calculated by the BRASSE V 
drape. 
 It is a conical collection bag made of plastic which has got 
calibrations at the bottom to measure the blood loss. 
 It is reusable. 
 It is inserted under the patient’s buttocks after the baby is 
delivered and cord is clamped and cut . 
 After collecting all the data, the data were tabulated and 
analysed. 
 
RESULTS 
Profile of cases studied 
Table:1 Age distribution 
Agein years GroupA 
No 
 
% 
GroupB 
No 
 
% 
20-24 70 70 68 68 
25-29 25 25 28 28 
30&above 5 5 4 4 
Total 100  100  
Mean 23.32  23.49  
S.D 2.947  3.164  
P p = 0.695  Not significant 
 
 Comparing the age distribution in both groups, majority of the 
patients were between 20-29 years 95% in Group A and 96% in 
Group B. Elderly group contributes to minority of the population 
(i.e) 5% in Group A and 4% in group B. 
 There is no significant difference in the mean age of the cases in 
both the groups.  
 
  
Table:2      Gravidity distribution 
Parity Group A 
No. 
 
% 
Group B 
No. 
 
% 
Primi 65 65 67 67 
Multi 35 35 33 33 
Total 100  100  
P p = 0.881   Not significant 
 
 In this study primigravidae were more compared to 
multigravidae. 
 In Group A-65% primi  35% multi 
 Group B-67%primi  33%multi 
          The parity of the two groups does not have statistically 
significant difference. 
 
 Table – 3     Type of labour 
Type of labour Group A 
No. 
 
% 
Group B 
No. 
 
% 
Spontaneous 52 52 45 45 
Gel Induced 17 17 14 14 
Augmentation 31 31 41 41 
Total 100  100  
P P =0.646  Not significant 
 
  The type of labour was compared in both the groups. 
Majority of the patients in the groups had spontaneous onset of 
labour.(Group A 52% Group B 45%) 
  Labour was induced in17% in Group A and 14% in Group B 
The type of labour did not differ significantly in both groups. 
 
 
 Table 4:  Method of delivery 
Mode of 
delivery 
Group A 
No. 
 
% 
Group B  
% 
LN 2 2 3 3 
LN withLP  2 2 -- -- 
LN with Epi 87 87 83 83 
Outlet 9 9 14 14 
Total 100  100  
 
 In comparing the mode of delivery in both the groups, maximum 
number of patients were delivered by Labour natural with 
episiotomy 87% in Group A and 83% in Group B.  9% in Group A 
and 14% in Group B. were delivered by outlet forceps.  
 
 
 
Table 5 - Duration of active stage +II stage of labor 
Duration in hrs Group A 
No. 
 
% 
Group B 
No. 
 
% 
1-2hrs50mts 58 58 54 54 
3-4hrs50mts 33 33 35 35 
5hrs and more 9 9 11 11 
Total 100  100  
Mean 2.72  2.97  
S.D. 1.38  1.39  
P value  p =   0.212  Not significant 
 
  In comparing the  active stage + third stage duration  majority 
had duration less than 3 hours 58% in Group A and 54% in Group 
B. 
 Only 9% in Group A  and  11% in Group B  had duration more 
than 5 hours. 
 The mean duration of labour in Group A is 2.72 hrs and 2.96hrs 
in Group B. 
  
 
Comparison of outcome parameters in the two groups 
Table 6 : Changes in Haemoglobin 
 GroupA 
At 
admission 
After 
delivery 
Group B 
At 
Admission 
After 
delivery 
Hb in gms 9.385 8.571 8.975 8.638 
S.D 0.748 0.869 0.625 0.639 
P value < 0.001 Significant 
 
  Hemoglobin level at admission is compared to the 
hemoglobin after delivery in both the groups. 
  Statistically there was significant difference in the changes in 
hemoglobin in the two groups. 
 
Table:7     Duration of third stage 
Duration in 
mts. 
Group A 
No. 
 
% 
Group B  
% 
< 2 10 10 54 54 
3-4 15 15 33 33 
5-6 37 37 10 10 
7-8 16 16 3 3 
9-10 14 14 - - 
11-14 4 4 - - 
>15 4 4 - - 
Mean 6.52  2.82  
S.D. 3.963  1.513  
P value p< 0.001  Significant 
   
 10% had third stage duration upto2minutes in Group A and 54% 
in Group B. 68% had third stage duration of 3-8minutes in Group A 
and 46% in Group B.  
  4% had more than 15 minutes in Group A and none of the 
patients in Group B exceeded 15 minutes. The mean duration of 
third stage in Group A is 6.52 minutes and 2.82 minutes in Group 
B.  
  There is statistically significant difference in the duration of 
third stage between both groups. 
Table8 : Amount of Blood Loss: 
Blood loss in 
ml 
Group A 
No. 
 
% 
GroupB 
No. 
 
% 
0-50 6 6 25 25 
51-199 34 34 43 43 
200-349 39 39 23 23 
350-499 14 14 6 6 
>500 7 7 3 3 
Mean 241.65  155.90  
S.D. 151.82  122.037  
P p< 0.001  Significant 
In Group A 40% had blood loss less than 200ml. 
In Group B 68% had blood loss less than 200ml. 
7% of the patients had blood loss of more than 500ml in 
GroupA and 3% in Group B. 
The mean blood loss for GroupA is 241.65ml and 155.90ml 
for Group B. 
The mean blood loss for Group A is  lower than that of Group 
B  and this difference is statistically significant. 
 
Table 9:  Use of Other Uterotonics 
Drugs Group A
No. 
 
% 
Group B % 
Methergine 31 31 23 23 
Methergine +synto.drip 11 11 6 6 
Methergine 
+Synto.drip+Prostadin 
5 5 3 3 
P value P = 0.416  Not significant 
 
31% needed methergin in Group A and 23% in Group B. 
5% needed prostadin also in Group A and 3% in Group B. 
The need for additional uterotonic is not statistically 
significant  between the two groups. 
 
  
Table 10: Need for Blood transfusion and Iron sucrose 
 Group-A Group-B 
 No. % No. % 
Blood transfusion 3 3 1 1 
Iron Sucrose 11 11 3 3 
P p = 0.628 Not significant 
 
 The need for postnatal blood transfusion for Group A is 
3% and 1% for Group B. 
 Iron sucrose was need for 11% in Group A and 3% in 
Group B. 
 
 
 
 
  
Table 11:Postpartum complications 
 
 The incidence of PPH is 4% in Group A and  2% in Group B. 
 The incidence of Retained placenta is 1% in Group A and 0% in 
Group B. 
 
 
 
 
 GroupA 
No. 
 
% 
GroupB 
No. 
 
% 
PPH 4 4 2 2 
Retained 
placenta 
1 1 0 0 
p P = 0.696 Not significant 
 Table 12 :  Maternal effects 24 hours after delivery 
Side effects Group A 
No. 
 
% 
Group B 
No. 
 
% 
Nausea 1 1 - - 
Vomiting 1 1 1 1 
Headache 1 1 1 1 
Surgical 
evacuation 
- - - - 
Fever 2 2 2 2 
Abdominal pain 27 27 29 29 
% 32 32 33 33 
 
 Side effects in Group A  like nausea  and vomiting was 
2% in Group A and 1% in Group B 
 Fever was present in 2% in Both the groups. 
 Abdominal pain was present in 27% in Group A and 
29% in Group B. 
 
 
DISCUSSION 
     Active management of third stage is one of the most 
important steps in prevention of postpartum hemorrhage. 
  This study was conducted in the Department of Obstetrics 
and Gynaecology, Government Rajaji Hospital, Madurai to assess 
the effect of intraumblical injection of oxytocin  on the third stage 
of labour in comparison with intramuscular oxytocin injection. 
 In this 100 patients were given 10units oxytocin intramuscularly 
at delivery of anterior shoulder. 
 Another 100 patients were given 20units oxytocin  diluted in 
20ml Normal saline intraumbilically soon after the cord clamping. 
Discussion of profile of cases studied: 
Age Group and Patient Selection 
 In our study, age group of patients studied varied from 20 to 
35years 
 90% of Group A were between 20-29years. 
 96% of Group B were between 20-29 years. 
This is similar to the study by Department of Obstetrics and 
Gynaecology,K.E.M.Hospital, Bombay which showed that the 
mean age of control and study group was 29.3yrs and 29.1yrs 
respectively. 
Parity 
 In our study Primigravida were more in both compared to 
Multigravida. All were Term Singleton Low risk pregnancies. 
 In Group A -65%-primi 35%-multi 
 In Group B -67%-primi 33%-multi 
 This is similar to the study by the Department of Obstetrics 
and Gynaecology and diagnostic imaging, Mississauga, 
0ntario which showed 40% multi and 60% primi in control 
group and 45% multi and 55% primi in study group.  
Type of labour 
  In our study majority of patients in both groups had 
spontaneous onset of labour. 
 Group A -52% spontaneous onset of labour. 
 Group B-45% spontaneous onset of labour. 
       Augmentation with oxytocin is done in 
 31% in Group A 
 41% in Group B 
 This is similar to the study by Department of Obstetrics and 
Gynaecology , Maternity Port Royal Hospital,Paris, France  
which showed that 60% had spontaneous onset of labour in 
study group and 57% in control group. 
Method of delivery 
  In our study maximum number of patients were delivered by 
labour natural with episiotomy 87% in Group A , 83% in Group B. 
 Instrumentation was 9% in Group A and 14% in Group B. 
This is similar to the study by Erzincan Military Hospital , Angers, 
France .90% were delivered by labour naturale in study group and 
95%  of the patients in control group. 
 
Duration of active stage+third stageof labour 
  91% of patients had duration of active+ third stage less than 
5hoursin Group A and 89% in Group B. 
  None of the patients had duration of labour  more than 8hrs . 
 This is comparable to the study by Guillermo carroli, Rosario, 
Argentina which showed that all patients had duration of labour 
less than 15hrs 
Comparison of outcome parameters in both groups 
Changes in hemoglobin 
 Haemoglobin estimation was done at admission of the patient 
and repeated 24-48 hrs after delivery. 
Mean haemoglobin level of Group A  
 At admission is 9.292gms% 
 After delivery is 8.571gms% 
      Mean haemoglobin level of Group B 
 At admission is 8.975gms% 
 After delivery is 8.638gms% 
  There is a statistically significant difference (p<0.001)in the 
changes of hemoglobin  in the 2 groups. 
  This is comparable to the study by Department of Obstetrics 
and Gynaecology,Atlanta medical centre, Atlanta , Georgia which 
showed 
Mean haemoglobin level of control group 
 At admission is 11.7gms% 
 After delivery is 9.9gms% 
Mean haemoglobin level of study group 
 At admission is 12.1gms% 
 After delivery is 10.8gms% 
Duration of third stage of labour 
  In our study   in Group A 62% had duration of third stage 
upto 6minutes. In Group B 97% had third stage duration upto 
6minutes. There is significant reduction in the duration of third 
stage in the patients given oxytocin intraumblically. 
  The mean duration of third stage of labour is shorter  in 
intraumblical group (6.52+/-3.9 compared to 2.82+/-1.8) 
    This result is similar to the study done  by Nada 
abud-alhur Al-Ebrahimi Department of Obstetrics and 
Gynaecology United Arab Emirates,   where the mean duration of 
third stage was 2.59 minutes in the study group and 7.67 minutes in 
the control group (p<0.001).  
Blood loss 
  In our study 40% of Intramuscular group had blood loss less 
than 200ml whereas 68% of intraumblical group had blood less 
than 200ml 
Mean blood loss of intramuscular group-241.65 ml 
Mean blood loss of intraumblical group -155.90 ml 
This result is comparable to the study done by Gungorduuk K, et al, 
Mardin Women and Children Hospital, Mardin, Turkey, which 
showed mean estimated blood loss was significantly lower in 
women treated with oxytocin compared with women in the placebo 
group (195.3+/-81.0 mL compared with 288.3+/-134.1 mL, 
respectively; P<.001).  
 The incidence of PPH (i.e) more than 500ml in Group A is 
4%and in Group B it is 2%. 
Use of other uterotonics 
 47% of Group A needed additional uterotonics and only 32% 
needed additional uterotonics in Group B.  
This result is comparable to the study done by Gazvani,Liverpool 
Women’s Hospital, U.K., which showed use of other uterotonics in 
40% in control group and 35% in study group. 
Postpartum complications 
  Retained placenta was present in 1% of the cases in Group A 
and 0% in Group B 
   This result is comparable to the study done by Tehseen et al 
Department of Obstetrics and Gynaecology, Sargodha which 
showed an incidence of 1.2% of retained placenta in control group 
only 
  Massive PPH requiring Blood transfusion was 3% in 
intramuscular group and 1% in intraumblical group. Iron sucrose 
was used in 11% of the cases in Group A and 3% of the cases in 
Group B. 
This comparable to the study by Edgardo abalos et al  which 
reduced risk of blood transfusion with intraumblical oxytocin 
injection(4% vs 2%) 
Maternal effects 24 hrs after delivery 
  Nausea, vomiting and headache was found in 3% in Group A 
and in 2% in Group B. 
  Surgical evacuation for retained placenta was not needed in 
both the groups. 
  Fever was present in 2% of the cases in both the groups. 
   This is comparable to the study done by Nada abud-
alhur Al-Ebrahimi, Department of Obstetrics and Gyynaecology, 
Arab Medical College  which showed a higher incidence of 
increased blood pressure following delivery in the active 
management group (RR, 3.46; 95% CI, 1.68-7.09). This group also 
had a higher incidence of nausea (RR, 1.83; 95% CI, 1.51-2.23) and 
vomiting (RR, 2.19; 95% CI, 1.68-2.86). The slight trend in manual 
removal of the placenta and the significant increases in the rates of 
hypertension, nausea, and vomiting appear to be a function of the 
chosen uterotonic. These effects are noted with ergot preparations 
and not with oxytocin. 
               Abdominal pain was present in 27% in Group A and 29% 
in Group B  
  This result is comparable to the study done by Tehseen et al , 
Department of Obstetrics and Gynaecology, Sargodha . Their study 
showed that abdominal pain was experienced in study group but the 
difference was not found statistically significant. 
 
SUMMARY 
  This study was conducted in Department of Obstetrics and 
Gynaecology, Government Rajaji Hospital, Madurai. Two hundred 
patients  under this study  were admitted in labour ward and  after 
considering the inclusion criteria and exclusion criteria were 
divided into Group A and Group B. 
Group A patients were given Oxytocin Intramuscularly 
Group B patients were given Oxytocin intraumbilically 
Results 
 Age:95% of the patients were between 20-29yrs in Group A 
and 96% in Group B 
 Parity : In Group A 65% were Primi and 35% were Multi. In 
Group B 67% were Primi and 33% were multi. 
 Type of labour  :   In group A 52% had spontaneous onset of 
labour and 17% had induced labour.  In group B, 45% had 
spontaneous onset of labour and 14% had induced labour. 
 Method of delivery :   87% in Group A and 83% in Group B 
were delivered by labour naturale with episiotomy. 9% in 
group A and 14\% in group B were delivered by outlet 
forceps. 
 Fall in Hb level is significantly less in group B which is 
statistically significant 
 Duration of 3rd stage :   The mean duration of third stage in 
Group A is 6.52 minutes and 2.82 min in Group B 
 Amount of blood loss :  The mean blood loss was 241.65 ml 
in group A, and 155.9 ml in group B 
 The user of other uterotonics  :  Methergine was needed in 
31% in group A and 23% in group B.  Prostadin was needed 
in 5% in group A and 3% in group B. 
 Blood transfusion and Iron sucrose : The need for postnatal 
blood transfusion for group A is 3% and for group B it is 
1%, Iron sucrose was needed for 11% in group A and 3% in 
groupB. 
 Postpartum complications   :  The  incidence of PPH is 4% 
in group A and 2% in group B. The incidence of retained 
placenta is 1% in group A and 0% in group B. 
 Maternal effects 24 hrs after delivery :   Nausea and 
vomiting was present in 2% in group A and 1% in group B. 
Fever was present in 2% in both the groups.   Abdominal 
pain was present in 27% in group A and 29% in group  B.  
Surgical evacuation of retained placental bits was 0% in 
both groups. 
 CONCLUSION 
 Intraumbilical oxytocin is very effective in the active 
management of third stage. 
1. It reduces the blood loss and duration of third stage of labour. 
In intra umbilical group 91% of patients had blood loss less 
than 350 ml 
2.  The mean duration of third stage was 2.82 minutes in intra 
umbilical group 
3. Complication of third stage like PPH is 2% in intra umbilical 
group and retained placenta is 0% in intraumbilical group.   
On Critical evaluation intra umbilical oxytocin is more potent 
in reducing the amount of blood loss and mean duration of 
third stage of labour compared to intra muscular oxytocin in 
low risk population 
4. Side effects like nausea, vomiting, headache, fever and 
abdominal pain are similar to intra muscular group. 
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PROFORMA 
CRITICAL ANALYSIS OF EFFECT OF INTRAUMBILICAL OXYTOCIN  
INJECTION ON 3RD STAGE OF LABOUR 
Name  :                                                   Age:                                    IP 
NO: 
Obstetric Code: 
LMP  : 
EDD  : 
Date  & Time of admission: 
Date & Time ofonset of active stage: 
Vitals before delivery:              HB:        gm%      PR:      /min         BP:                
mm Hg 
Vitals 24-48hrs after delivery: HB:        gm%      PR:      /min         BP:                
mm Hg 
Gel induction  :  
Synto acceleration  : 
Date & Time of baby delivery:                                              Birth weight:                
Mode of delivery  : 
Duration  of I+II Stage : 
Date &timeof delivery of placenta: 
Duration of III Stage  : 
 III Stage >15 min   : 
III Stage >30 min   : 
Usage of methergin   : 
Usage of IV Synto drip  : 
Manual removal of Placenta : 
Amount of blood loss  : 
Mild PPH>500ml  : 
Severe PPH>1000ml : 
Need for blood transfusion:                             No of units: 
Nausea   : 
Vomiting   : 
Headache   : 
Subsequent surgical evacuation of retained placental bits: 
Fever in postnatal period : 
Abdominal pain in postnatal period: 
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